An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.

Roche

Status: Completed

Conditions: Rheumatoid Arthritis

Treatments: Other: Routine clinical practice

Study type: Observational

Funder types: Industry

Identifiers

NCT02590562

ML28487

Details and patient eligibility

About

This observational study will describe the treatment patterns of usage of biological DMARDs in routine clinical practice and the demographics and RA disease characteristics in patients suffering from rheumatoid arthritis. Patients will be recruited and examined the same day when recruited. There will be no follow up visit or treatment period only one visit in this study.

Enrollment: 808 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients at least 18 years of age.
• Patients with a diagnosis of RA according to the revised ACR criteria.
• Patients receiving treatment of launched biological DMARDs.

Exclusion criteria

• Patients who received biological DMARDs due to clinical trials or biologics not launched.
• Patients who are considered not appropriate for study due to other reasons at physicians' discretion.

Trial design

808 participants in 1 patient group

RA patients treated with routine clinical practice

Description:

Describe in routine clinical practice the treatment patterns of usage of biological DMARDs in patients suffering from RA including frequency of monotherapy, biological DMARDs usage status (types, dosage), concomitant DMARDs usage information (type and dosage)

Treatment:

Other: Routine clinical practice